We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microarray Workstation Eliminates Ozone Effects

By Biotechdaily staff writers
Posted on 09 Feb 2006
A new workstation processes microarrays in an ozone-safe environment that eliminates the effects of this air pollutant on array data variability. More...


Scientists from SciGene (Sunnyvale, CA, USA) and Stanford University (Stanford, Ca, USA) presented results at the LabAutomation 2006 conference from studies using SciGene's BriteSpot microarray workstation to examine the effects of ozone on microarray data. This workstation processes arrays in an ozone-safe environment, eliminating the effects of ozone on array data variability.

The BriteSpot system is one of a series of products being developed by the company to improve sensitivity and reliability of microarrays. Components of the workstation include a bench top heating unit for incubating up to 16 arrays in racks ready for processing, a robotic system that processes up to 24 arrays through five temperature-controlled baths into an integral centrifuge for drying, and a NoZone workspace. This is a sealed enclosure with filtration and monitoring equipment that maintains an ozone-safe environment.

Laboratory levels of ozone can degrade fluorescent dyes commonly used in microarray applications. New studies have shown that the effect of ozone is not uniform and leads to spatial distortion of signals across the arrays. This can lead to errors identifying differentially expressed genes when arrays are processed in the presence of nominal levels of ozone within a laboratory.

SciGene is a privately held company founded in 2003, which provides instruments that are used in process control, automation, and protocol optimization to reduce microarray data errors and to enable researchers to obtain reliable results more rapidly.




Related Links:
SciGene

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.